TELA Bio (TELA) Other financing activities (2018 - 2026)

TELA Bio's Other financing activities history runs 9 years deep, the most recent figure standing at $27000.0 for Q1 2026.

• On a quarterly basis, Other financing activities fell 55.0% year-over-year to $27000.0 in Q1 2026; TTM through Mar 2026 was $3.5 million, a 1889.27% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 1164.77% from the prior year.
• Other financing activities eased to $27000.0 in Q1 2026 per TELA's latest filing, from $3.4 million in the prior quarter.
• Across five years, Other financing activities topped out at $3.4 million in Q4 2025 and bottomed at -$59000.0 in Q2 2025.
• The 5-year median for Other financing activities is $44000.0 (2023), against an average of $496600.0.
• Across the five-year window, Other financing activities plunged 99.61% in 2022 and soared 11600.0% in 2024, its largest moves.
• Year by year, Other financing activities stood at $3.4 million in 2022, then slumped by 99.25% to $26000.0 in 2023, then soared by 350.0% to $117000.0 in 2024, then jumped by 2847.86% to $3.4 million in 2025, then plunged by 99.22% to $27000.0 in 2026.
• Per Business Quant, the three latest TELA Other financing activities figures stand at $27000.0 (Q1 2026), $3.4 million (Q4 2025), and $104000.0 (Q3 2025).